Natalie Chen, MD

breast medical oncologist

Natalie Chen, MD is a breast medical oncologist at Baylor College of Medicine, with clinical and research interests spanning the rapidly evolving landscape of hormone receptor-positive breast cancer, including novel oral endocrine agents, targeted combinations, and molecular monitoring strategies.

Published Articles (1)

ER-Positive Breast Cancer in 2026: New Oral Endocrine Agents and the Case for ctDNA-Guided Switching

October 7, 2026

Despite substantial treatment advances, roughly a quarter of patients with early-stage ER-positive breast cancer still develop recurrence within five years